Show simple item record

dc.contributor.authorAberoumandi, SM
dc.contributor.authorMohammadhosseini, M
dc.contributor.authorAbasi, E
dc.contributor.authorSaghati, S
dc.contributor.authorNikzamir, N
dc.contributor.authorAkbarzadeh, A
dc.contributor.authorPanahi, Y
dc.contributor.authorDavaran, S
dc.date.accessioned2018-08-26T07:21:51Z
dc.date.available2018-08-26T07:21:51Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/46181
dc.description.abstractCancer is a main public health problem that is known as a malignant tumor and out-of-control cell growth, with the potential to assault or spread to other parts of the body. Recently, remarkable efforts have been devoted to develop nanotechnology to improve the delivery of anticancer drug to tumor tissue as minimizing its distribution and toxicity in healthy tissue. Nanotechnology has been extensively used in the advance of new strategies for drug delivery and cancer therapy. Compared to customary drug delivery systems, nano-based drug delivery method has greater potential in different areas, like multiple targeting functionalization, in vivo imaging, extended circulation time, systemic control release, and combined drug delivery. Nanofibers are used for different medical applications such as drug delivery systems.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectNanofiber
dc.subjectcancer therapy
dc.subjectdrug delivery
dc.subjectnanotechnology
dc.titleAn update on applications of nanostructured drug delivery systems in cancer therapy: a review
dc.typeReview
dc.citation.volume45
dc.citation.issue6
dc.citation.spage1058
dc.citation.epage1068
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1080/21691401.2016.1228658


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record